Valuation: GC Corp.

Market Cap 414B 308M 275M 255M 232M 437M 29.16B 445M 3.07B 1.2B 15.21B 1.16B 1.13B 48.68B P/E 2024
33.4x
P/E 2025 -10.6x
Enterprise Value 1,808B 1.34B 1.2B 1.12B 1.01B 1.91B 127B 1.94B 13.4B 5.24B 66.46B 5.05B 4.94B 213B EV / Sales 2024
0.83x
EV / Sales 2025 0.86x
Free-Float
43.96%
Yield 2024
2.89%
Yield 2025 1.88%
1 day-3.29%
1 week-6.56%
Current month-4.21%
1 month-5.60%
3 months-6.37%
6 months-34.88%
Current year-42.78%
1 week 8,990
Extreme 8990
9,890
1 month 8,990
Extreme 8990
10,150
Current year 8,630
Extreme 8630
18,010
1 year 8,630
Extreme 8630
18,010
3 years 8,630
Extreme 8630
18,490
5 years 8,630
Extreme 8630
31,150
10 years 8,630
Extreme 8630
56,300
Manager TitleAgeSince
Chief Executive Officer 52 2010-02-28
Chief Executive Officer 72 2010-03-24
Corporate Officer/Principal 43 -
Director TitleAgeSince
Chairman 72 2010-12-16
Director/Board Member 76 2009-02-28
Director/Board Member 52 2010-02-28
Date Insider Type Main position Quantity % Market Cap. Importance
4/25/25 Buy

Chief Executive Officer

1,334 0.0028%
4/25/25 Buy

Chief Executive Officer

3,191 0.0068%
4/25/25 Buy

Chief Executive Officer

6,748 0.0143%
Change 5-day change 1-year change 3-year change Capi.($)
-3.29%-6.56%-41.34%-35.16% 309M
+3.55%+7.01%+51.42%+105.45% 1,116B
-0.25%-1.25%+32.49%+61.48% 610B
-0.03%+4.03%+25.28%+91.54% 501B
-1.48%+1.97%+72.62%+39.59% 358B
-1.21%+5.11%+31.83%+49.16% 366B
-1.60%+4.21%+18.96%+42.34% 288B
-2.05%+3.94%-0.66%+13.66% 261B
+1.86%+6.53%+45.98%+52.77% 235B
+2.49%+6.98%+33.03%+102.67% 195B
Average -0.38%+4.08%+26.96%+52.35% 393.01B
Weighted average by Cap. +0.24%+4.93%+38.17%+71.59%

Financials

2024 2025
Net sales 2,205B 1.64B 1.46B 1.36B 1.24B 2.33B 155B 2.37B 16.35B 6.4B 81.06B 6.16B 6.02B 259B 2,451B 1.82B 1.63B 1.51B 1.38B 2.59B 173B 2.64B 18.17B 7.11B 90.12B 6.84B 6.7B 288B
Net income 24.03B 17.87M 15.95M 14.83M 13.49M 25.37M 1.69B 25.83M 178M 69.68M 883M 67.07M 65.65M 2.83B -69.51B -51.71M -46.16M -42.9M -39.02M -73.42M -4.9B -74.74M -515M -202M -2.56B -194M -190M -8.18B
Net Debt 1,042B 775M 692M 643M 585M 1.1B 73.42B 1.12B 7.72B 3.02B 38.31B 2.91B 2.85B 123B 1,394B 1.04B 926M 860M 783M 1.47B 98.22B 1.5B 10.33B 4.04B 51.25B 3.89B 3.81B 164B
Projected Income Statement - Annual - GC Corp.
Logo GC Corp.
Green Cross Holdings is a Korea-based holding company principally engaged in the manufacture and distribution of pharmaceuticals. The Company operates its business through five segments. The Pharmaceutical Manufacturing and Sale segment mainly manufactures and sells blood products, general pharmaceuticals, vaccines and over-the-counter (OTC) drugs. The Medical Service and System Development and Supply segment primarily provides healthcare services. The Diagnostic and Analysis segment mainly engages in blood diagnostics and genetic analysis business. The Leasing and Service Business segment is primarily involved in the real estate leasing and the management of affiliated group companies. The Other segment mainly operates livestock operation and other business.
Employees
142
Date Price Change Volume
26-10-15 ₩9,110.00 -3.29% 71,855
26-10-14 ₩9,420.00 -0.95% 24,122
26-10-13 ₩9,510.00 -0.73% 72,592
26-10-12 ₩9,580.00 -1.74% 55,985
26-10-08 ₩9,750.00 -1.91% 54,327
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
B
  1. Stock Market
  2. Stocks
  3. A005250 Stock